Mounjaro vs Zepbound
Mounjaro and Zepbound are the tirzepatide pair: two brand names for exactly the same active ingredient, made by the same manufacturer, using the same dose steps. Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight management and for obstructive sleep apnea in adults with obesity. This page explains what the two labels change in practice: how maintenance dosing is framed, what the trial result belongs to, and why the list prices and coverage differ slightly.
One ingredient, two labels
| Detail | Mounjaro | Zepbound |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide, exactly the same ingredient |
| Approved for | Type 2 diabetes | Weight management, and obstructive sleep apnea in adults with obesity |
| How often | One injection, once a week | One injection, once a week |
| Max weekly dose | 15 mg | 15 mg, with label maintenance doses of 5 mg, 10 mg or 15 mg |
| Trial result | Its approval trials were built around blood sugar control in type 2 diabetes | In SURMOUNT-1, people on the 15 mg dose lost an average of 20.9 percent of body weight over 72 weeks |
| About list price per month | About $1,080 | About $1,060 |
Because the ingredient is identical and even the dose steps match, the differences on this page are about the labels: the condition each product is approved to treat, how the maintenance dose is framed, and the coverage that follows.
How they differ in practice
Uniquely among the pairs on this site, these two share the same escalation schedule as well as the same ingredient: start at 2.5 mg once weekly, rise to 5 mg after at least four weeks, then climb in 2.5 mg steps to a maximum of 15 mg. Where the labels differ is the endgame. The Mounjaro label treats increases as optional steps toward blood sugar goals. The Zepbound label names 5 mg, 10 mg and 15 mg as the recommended maintenance doses for weight management, so staying partway up the schedule is a normal, planned outcome. The Mounjaro dosage chart, the Zepbound dosage chart and the combined tirzepatide dosage chart show the schedules in full.
Side effects compared
With the same ingredient and the same dose steps, the side effect profiles are effectively the same list: nausea, vomiting, diarrhea and constipation lead both labels, along with the same serious warnings. Tolerability comes down to the person and the dose, not the brand name on the box. The Mounjaro side effects page, the Zepbound side effects page and the shared tirzepatide side effects page cover the profile in full.
Who each is usually prescribed for
Mounjaro is the label for adults with type 2 diabetes. Zepbound is the label for weight management, and it also carries an approval for obstructive sleep apnea in adults with obesity. Insurance coverage normally follows the label, so the condition being treated usually decides which name is on the prescription. Using one product for the other's approved purpose would be off label use, which is a decision only a prescriber can make.
Switching between them
People are sometimes moved between these two labels when the treatment goal changes, for example when weight becomes the main focus of care. Even with the same ingredient and the same steps, switching is a prescriber decision, never a self switch, because the prescription, the coverage and the treatment target all change with the label. Your prescriber will confirm the dose and the timing. Never run the two products in parallel.
Frequently asked questions
Is Mounjaro the same as Zepbound?
The active ingredient is identical: both are tirzepatide, made by Eli Lilly, with the same once weekly dose steps from 2.5 mg to a 15 mg maximum. The products differ in their approved uses. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management and for obstructive sleep apnea in adults with obesity.
Why does Zepbound name set maintenance doses?
The Zepbound label recommends maintenance doses of 5 mg, 10 mg or 15 mg once weekly for weight management, so remaining on a middle dose long term is a planned outcome rather than an unfinished climb. The Mounjaro label instead frames each increase as an optional step taken when more blood sugar effect is needed.
Which is cheaper, Mounjaro or Zepbound?
They are nearly tied at list price: about $1,080 a month for Mounjaro and about $1,060 for Zepbound. In practice the deciding factor is coverage, which usually follows the label, so a diabetes plan covers Mounjaro and a weight management benefit covers Zepbound.
Can Mounjaro be used for weight loss instead of Zepbound?
Weight management is Zepbound's approved use, not Mounjaro's. Prescribing Mounjaro for weight would be off label use, which only a prescriber can decide on, and insurers often decline to cover a product outside its label. If weight is the goal, raise the weight management label with your prescriber.
Can I switch from Mounjaro to Zepbound?
Yes, it happens when treatment goals change, but it is a prescriber decision, never a self switch. The ingredient and steps are the same, yet the prescription, its approved purpose and its coverage all change, so your prescriber will confirm the dose and the timing. Never use both products at the same time.